...
首页> 外文期刊>Human mutation >Analysis of BRCA1 Variants in Double-Strand Break Repair by Homologous Recombination and Single-Strand Annealing
【24h】

Analysis of BRCA1 Variants in Double-Strand Break Repair by Homologous Recombination and Single-Strand Annealing

机译:通过同源重组和单股退火的双链断裂修复中BRCA1变体分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Missense substitutions of uncertain clinical significance in the BRCA1 gene are a vexing problem in genetic counseling for women who have a family history of breast cancer. In this study, we evaluated the functions of 29 missense substitutions of BRCA1 in two DNA repair pathways. Repair of double-strand breaks by homology-directed recombination (HDR) had been previously analyzed for 16 of these BRCA1 variants, and 13 more variants were analyzed in this study. All 29 variants were also analyzed for function in double-strand break repair by the single-strand annealing (SSA) pathway. We found that among the pathogenic mutations in BRCA1, all were defective for DNA repair by either pathway. The HDR assay was accurate because all pathogenic mutants were defective for HDR, and all nonpathogenic variants were fully functional for HDR. Repair by SSA accurately identified pathogenic mutants, but several nonpathogenic variants were scored as defective or partially defective. These results indicated that specific amino acid residues of the BRCA1 protein have different effects in the two related DNA repair pathways, and these results validate the HDR assay as highly correlative with BRCA1-associated breast cancer. Missense substitutions of uncertain clinical significance in the BRCA1 gene are a vexing problem in genetic counseling for women who have a family history of breast or ovarian cancer. In this study, we evaluated whether functional assays for DNA repair can augment the genetic information. We found that the effects of BRCA1 missense substitutions on protein function in homologous recombination repair of DNA double strand breaks were predictive of disease association. ? 2012 Wiley Periodicals, Inc.
机译:BRCA1基因中不确定的临床意义的致命取代是具有乳腺癌家族史的妇女遗传咨询中的烦恼问题。在本研究中,我们评估了BRCA1在两种DNA修复途径中的29个小畸义取代的功能。通过先前分析了通过同源定向的重组(HDR)的双链断裂的修复,其中16种BRCA1变体中的16个,并在本研究中分析了13种变体。通过单链退火(SSA)途径,还分析了所有29种变体用于双链断裂修复的功能。我们发现,在BRCA1的致病性突变中,所有途径都对DNA修复有缺陷。 HDR测定是准确的,因为所有致病突变体对HDR有缺陷,并且所有的非致病变体都是HDR的全功能性。通过SSA准确地识别致病突变体的修复,但是几种非暴力变体被评分为缺陷或部分有缺陷。这些结果表明,BRCA1蛋白的特定氨基酸残基在两个相关的DNA修复途径中具有不同的效果,这些结果验证了HDR测定与BRCA1相关的乳腺癌高度相关性。 BRCA1基因中不确定的临床意义的密码取代是遗传咨询的遗传咨询,用于患有乳腺癌或卵巢癌的家族史。在本研究中,我们评估了DNA修复的功能测定是否可以增加遗传信息。我们发现,BRCA1畸形取代对DNA双链休息的同源重组修复中蛋白质功能的影响是预测的疾病协会。还2012 Wiley期刊,Inc。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号